This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SHOW MORE NRx Pharmaceuticals advances NRX-100, a preservative-free ketamine, through a fast-tracked FDA review for treating suicidal depression and PTSD. Sanom/Adobestock BREAKING NEWS A new formulation of ketamine is progressing through a novel US Food and Drug Administration review pathway, announced NRx Pharmaceuticals.
The top 4 disease states this quarter were schizophrenia (41.7%), major depressive disorder (25%), and treatment-resistant depression (16.7%), and suicidal depression (16.7%). MM120 ODT is a proprietary, pharmaceutically optimized form of lysergic acid diethylamide (LSD).
link] Newsletter Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients. Subscribe Now!
NRx Pharmaceuticals seeks FDA approval for NRX-100, a preservative-free ketamine for suicidal depression and PTSD, via the National Priority Voucher pathway. Ecopipam has demonstrated long-term safety and efficacy in reducing tic severity in pediatric patients with Tourette syndrome, with no tachyphylaxis observed.
She has also served as advisory board participant for Supernus Pharmaceuticals and Axsome Therapeutics. Ms Barbee is a physician associate at Southlake Psychiatry in Davidson, North Carolina. She serves on speaker bureaus for Neurocrine Biosciences, Axsome Therapeutics, and Alkermes.
Dzmitry/AdobeStock On Friday July 18, 2025, the US Food and Drug Administration (FDA) advisory committee will discuss the supplemental New Drug Application (sNDA) for brexpiprazole (Rexulti) tablets, submitted by Otsuka Pharmaceutical Company, for the treatment of adults with posttraumatic stress disorder (PTSD), in combination with sertraline.
You identify two main drivers behind this rise: first, the explosion of pharmaceutical advertising in the 1990s, and second, the growing expectation that we must constantly market and network ourselves as prerequisites for a successful life. Take multiple personalitydisorder , for example.
Download Issue PDF Articles in this issue History, Physiology, and Pharmacology of Incretins Newsletter Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients. Subscribe Now!
A third example includes the historical diagnosis of Masochistic PersonalityDisorder specifically applied to women who remained in abusive relationships, a sleight of hand which again involves blaming the victim, rather than placing the problem within the perpetrator, or even the system that enables it (Herman, 1997).
Pharmaceutical companies, exerting their influence on academic psychiatry through lucrative honoraria and advisory board payments, have clearly played a role in how antidepressant risks have been presented. Their protests to the contrary have even been seen as indications of a personalitydisorder.
There I talk about depression, I talk about some of the so-called personalitydisorders. Moore: And of course, it was an open door then for the pharmaceutical industry, wasn’t it, with their massive marketing dollars. ” One person I really have come to respect quite a lot is Joanna Moncrieff.
The people in our research started to recognizethese signals and are now able to choose a better way or ask for help way before it ends up in the emergency roomthis is real recovery; this is innate health in action and no pharmaceuticals or torturous surgery needed. So why couldn’t these doctors see this?
On top of it, during the last few years, when I spent more time detained in hospital than at home, some of the nurses accused me of “not wanting to get better” and urged the doctors to label me with “personalitydisorder.” As a last resort, I underwent experimental psychosurgery in September 2001 (bilateral anterior cingulotomy).
The same is true of attempts to reframe other diagnostic labels as ‘identities’—including the most contentious, ‘borderline personalitydisorder’ which, it is suggested, can be ‘destigmatised’ through ‘ neuroqueer feminism ’. Neuroqueer Feminism: Turning with Tenderness toward Borderline PersonalityDisorder. Johnson, M.
Everything that I had been told was part of an elaborate, profiteering form of mass human control by psychiatrists, pharmaceutical companies, and governments. In my desperation and loneliness, I had been the perfect psychiatric victim. I asked my psychiatrist during our final consultation. Only a little bit,” they nonchalantly responded.
Siem: You don’t serve the pharmaceutical company who might be paying you on the side. It’s a basic shift of perspective that can literally change a person’s life. You don’t serve the hospital. You don’t serve the clinic that hired you. You don’t serve the CEO. You serve the patient. Nardi: Perfect, right.
The mental health industry, including therapists, pharmaceutical companies, and even heads of departments and trauma experts, have a vested interest in diagnosing as many individuals as possible. It is a serious disorder, reflecting the deep psychological scars left by genuine trauma.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content